Delhi constitutes Medical Termination of Pregnancy Medical Boards

The establishment of these Medical Boards signifies a concerted effort to ensure the smooth and lawful execution of the Medical Termination of Pregnancy Act, 1971. It is crucial to note that each Medical Board must include at least one female member. In situations where a board member is unavailable during discussions on a specific case, suitable substitutions may be made by the Chairperson.

WHO Issues Alert Over Fake DEFITELIO Drug in India and Turkey

The WHO emphasizes the importance of purchasing medications only from reputable sources and urges healthcare providers to remain vigilant in verifying the authenticity of the products they prescribe and dispense. Patients should also take an active role in confirming the legitimacy of their medications to safeguard their health.

Advisory for Hospitals in Delhi

The advisory states that it is essential that all hospitals in the capital region remain fully prepared to cater to any medical needs for the G20 delegates and general public. Hence, all hospitals in Delhi shall be on high alert from 7th September, 2023 to 11th September, 2023.

Kerala State Pharmacy Council has launched a Skill Development Course for pharmacists

Kerala State Pharmacy Council and Kerala Institute for Local Administration (KILA) are jointly conducting a Skill Development Course from 13th to 17th September (5 Days Full Time Residential Programme). Visit ( www.kspconline.in ) Tel : 9961373770 to join the course conducted by experts, doctors and management experts from various fields with the aim of empowering our pharmacists to meet the modern technologies, advancements and challenges in the field of pharmacy.

CDSCO issues alert on Falsified Versions of Adcetris Injection

Patients and healthcare professionals are urged to remain vigilant and cautious in their dealings with Adcetris Injections, seeking only authorized sources and promptly reporting any unusual reactions or suspicions regarding the medication. These measures will help ensure that patients receive genuine and effective treatments while safeguarding them from potentially harmful counterfeit drugs.

Alert Issued by DCGI on Abbott India’s Digene Gel

The Drugs Controller General of India (DCGI) has issued a precautionary alert concerning Abbott India’s antacid product, Digene gel, manufactured at its Goa facility. This action follows Abbott India’s disclosure that certain batches of the product have been subject to complaints regarding their color and taste, which deviated from the normal standards.

National Medical Commission (NMC) has decided that thursday (11:00 a.m. to 1:00 p.m.) of every week is designated as redressal/public hearing time

Secretary NMC, with officials from all divisions, shall be hearing all the aggrieved representatives/ person/candidates etc. during this time. Those who wish to present their grievance in person may send brief details of their grievance at least 2 days in advance by email to grievance cell in nmc.orq.in. Upon receipt of confirmation of the date, applicant can schedule a physical visit. A maximum of 2 individuals for each matter may please remain present at the assigned date.